Cargando…
Intravitreal Bevacizumab (Avastin) as an Adjuvant Therapy for Choroidal Carcinoid Metastasis
PURPOSE: To report a case of choroidal carcinoid metastasis with neovascularization of the optic disc and macular edema that was treated with three sessions of intravitreal anti-vascular endothelial growth factor (anti-VEGF) as an adjuvant therapy with photodynamic therapy (PDT). METHODS: A 16-year-...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7861107/ https://www.ncbi.nlm.nih.gov/pubmed/33553848 http://dx.doi.org/10.4103/JOCO.JOCO_54_20 |
_version_ | 1783647019618795520 |
---|---|
author | Karimi, Saeed Arabi, Amir Shahraki, Toktam |
author_facet | Karimi, Saeed Arabi, Amir Shahraki, Toktam |
author_sort | Karimi, Saeed |
collection | PubMed |
description | PURPOSE: To report a case of choroidal carcinoid metastasis with neovascularization of the optic disc and macular edema that was treated with three sessions of intravitreal anti-vascular endothelial growth factor (anti-VEGF) as an adjuvant therapy with photodynamic therapy (PDT). METHODS: A 16-year-old patient with a diagnosis of lung carcinoid tumor presented to an ophthalmology clinic with a complaint of decreased vision in his right eye. Fundus examination revealed choroidal carcinoid metastasis in addition to neovascularization of the optic disc. Macular optical coherence tomography revealed cystoid macular edema and subretinal fluid. The patient was treated with PDT in addition to three sessions of intravitreal anti-VEGF injections. RESULTS: Following the treatment, the new vessels regressed, and visual acuity improved. Furthermore, central retinal thickness reduced significantly. The tumor size reduced significantly over a follow-up period of 6 weeks. CONCLUSION: Choroidal carcinoid metastasis may be complicated by neovascularization of optic disc, which responds favorably to intravitreal injections of bevacizumab. |
format | Online Article Text |
id | pubmed-7861107 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-78611072021-02-05 Intravitreal Bevacizumab (Avastin) as an Adjuvant Therapy for Choroidal Carcinoid Metastasis Karimi, Saeed Arabi, Amir Shahraki, Toktam J Curr Ophthalmol Case Report PURPOSE: To report a case of choroidal carcinoid metastasis with neovascularization of the optic disc and macular edema that was treated with three sessions of intravitreal anti-vascular endothelial growth factor (anti-VEGF) as an adjuvant therapy with photodynamic therapy (PDT). METHODS: A 16-year-old patient with a diagnosis of lung carcinoid tumor presented to an ophthalmology clinic with a complaint of decreased vision in his right eye. Fundus examination revealed choroidal carcinoid metastasis in addition to neovascularization of the optic disc. Macular optical coherence tomography revealed cystoid macular edema and subretinal fluid. The patient was treated with PDT in addition to three sessions of intravitreal anti-VEGF injections. RESULTS: Following the treatment, the new vessels regressed, and visual acuity improved. Furthermore, central retinal thickness reduced significantly. The tumor size reduced significantly over a follow-up period of 6 weeks. CONCLUSION: Choroidal carcinoid metastasis may be complicated by neovascularization of optic disc, which responds favorably to intravitreal injections of bevacizumab. Wolters Kluwer - Medknow 2020-12-12 /pmc/articles/PMC7861107/ /pubmed/33553848 http://dx.doi.org/10.4103/JOCO.JOCO_54_20 Text en Copyright: © 2020 Journal of Current Ophthalmology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Case Report Karimi, Saeed Arabi, Amir Shahraki, Toktam Intravitreal Bevacizumab (Avastin) as an Adjuvant Therapy for Choroidal Carcinoid Metastasis |
title | Intravitreal Bevacizumab (Avastin) as an Adjuvant Therapy for Choroidal Carcinoid Metastasis |
title_full | Intravitreal Bevacizumab (Avastin) as an Adjuvant Therapy for Choroidal Carcinoid Metastasis |
title_fullStr | Intravitreal Bevacizumab (Avastin) as an Adjuvant Therapy for Choroidal Carcinoid Metastasis |
title_full_unstemmed | Intravitreal Bevacizumab (Avastin) as an Adjuvant Therapy for Choroidal Carcinoid Metastasis |
title_short | Intravitreal Bevacizumab (Avastin) as an Adjuvant Therapy for Choroidal Carcinoid Metastasis |
title_sort | intravitreal bevacizumab (avastin) as an adjuvant therapy for choroidal carcinoid metastasis |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7861107/ https://www.ncbi.nlm.nih.gov/pubmed/33553848 http://dx.doi.org/10.4103/JOCO.JOCO_54_20 |
work_keys_str_mv | AT karimisaeed intravitrealbevacizumabavastinasanadjuvanttherapyforchoroidalcarcinoidmetastasis AT arabiamir intravitrealbevacizumabavastinasanadjuvanttherapyforchoroidalcarcinoidmetastasis AT shahrakitoktam intravitrealbevacizumabavastinasanadjuvanttherapyforchoroidalcarcinoidmetastasis |